These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6259671)

  • 41. [Possible utility of beta-cyclodextrin complexation in the preparation of biphenyl acetic acid suppositories].
    Uekama K; Maeda T; Arima H; Irie T; Hirayama F
    Yakugaku Zasshi; 1986 Dec; 106(12):1126-30. PubMed ID: 3559906
    [No Abstract]   [Full Text] [Related]  

  • 42. [Benzylisoquinoline alkaloid reactions with barbiturates. Reaction of papaverine with sodium phenobarbital. III. Avoidance of incompatibility by using the beta-cyclodextrin inclusion complex].
    Rácz I; Plachy J; Szabóné Tábori M; Stadlerné Szöke A; Vikmon M; Szejtli J
    Acta Pharm Hung; 1984 Jul; 54(4):154-9. PubMed ID: 6485810
    [No Abstract]   [Full Text] [Related]  

  • 43. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of water structure on cyclodextrin inclusion and light sensitivity of epinephrine].
    Hüttenrauch R; Fricke S; Knop M
    Pharmazie; 1985 Mar; 40(3):199-200. PubMed ID: 4023038
    [No Abstract]   [Full Text] [Related]  

  • 45. [Preparation and investigation of products containing metronidazole and beta-cyclodextrin].
    Kata M; Antal A
    Acta Pharm Hung; 1984 May; 54(3):116-22. PubMed ID: 6464773
    [No Abstract]   [Full Text] [Related]  

  • 46. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
    Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Improvements of some pharmaceutical properties of aralkylalcohols by cyclodextrin complexation].
    Uekama K; Oh K; Hirayama F; Otagiri M; Shibata M; Ohtani Y; Yamada Y; Sugiyama Y
    Yakugaku Zasshi; 1982 Dec; 102(12):1141-9. PubMed ID: 7182449
    [No Abstract]   [Full Text] [Related]  

  • 49. [Inclusion compounds of 8 Chinese medicinal volatile oils with beta-cyclodextrin].
    Li SZ; Guan SJ
    Zhong Yao Tong Bao; 1987 Dec; 12(12):27-32, 58-9. PubMed ID: 3446391
    [No Abstract]   [Full Text] [Related]  

  • 50. Study of insolubility problems of dexamethasone and digoxin: cyclodextrin complexation.
    Dilova V; Zlatarova V; Spirova N; Filcheva K; Pavlova A; Grigorova P
    Boll Chim Farm; 2004; 143(1):20-3. PubMed ID: 15085571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
    Wu WM; Wu J; Bodor N
    Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate.
    Bodor N; Drustrup J; Wu W
    Pharmazie; 2000 Mar; 55(3):206-9. PubMed ID: 10756542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inclusion compounds of lankacidin-group antibiotics with cyclodextrins.
    Harada S; Okada J; Takeda M; Yamazaki T
    J Antibiot (Tokyo); 1985 Jul; 38(7):877-85. PubMed ID: 4030501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin.
    Tommasini S; Calabrò ML; Raneri D; Ficarra P; Ficarra R
    J Pharm Biomed Anal; 2004 Oct; 36(2):327-33. PubMed ID: 15496325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of a phenytoin beta-cyclodextrin complex and evaluation of a suspension and a tablet dosage form prepared from the complex.
    Hegde RP; Rhodes CT
    Pharm Acta Helv; 1985; 60(2):53-7. PubMed ID: 3991746
    [No Abstract]   [Full Text] [Related]  

  • 60. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
    Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
    Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.